ILMN was $56 when you stated that last year. It then plummeted to $26 and only recovered partly to $44 now because of Roche buyout interest. Since CEO has told Roche three times to get lost, Roche has been looking at other companies.
Check back to see how you feel about Roche's new move.
Meanwhile, recall the fond memories of Illumina's rough road: